Hemoglobin SC Disease
Information
- Disease name
- Hemoglobin SC Disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00005783 | Completed | Phase 1 | A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders | March 2000 | October 2000 |
| NCT00600665 | Completed | N/A | Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease | February 2007 | June 2014 |
| NCT00860782 | Completed | N/A | Parent Educational Program for Children With Sickle Cell Disease | August 2008 | May 2016 |
| NCT01356485 | Completed | Phase 1 | Safety Study of MP4CO in Adult Sickle Cell Patients | January 2012 | December 2012 |
| NCT02336373 | Terminated | Phase 2 | Treatment of Hemoglobin SC Disease With Hydroxyurea | December 2014 | March 31, 2017 |
| NCT02640573 | Terminated | Phase 2 | Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE) | October 12, 2015 | November 16, 2017 |
| NCT00034528 | Terminated | Phase 2 | Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia | September 2001 | November 2003 |
| NCT00040456 | Terminated | Phase 2 | Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate | January 2001 | May 2006 |
| NCT00532883 | Terminated | Phase 2 | Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease | January 2007 | August 2009 |
| NCT01925001 | Withdrawn | Phase 2 | Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis | October 2013 | October 2015 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006450